Kestra Medical Technologies (KMTS) 10K Form and Latest SEC Filings 2026

Kestra Medical Technologies logo
$26.63 -1.66 (-5.87%)
Closing price 04:00 PM Eastern
Extended Trading
$26.65 +0.02 (+0.08%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Kestra Medical Technologies SEC Filings & Recent Activity

Kestra Medical Technologies (NASDAQ:KMTS) has submitted 146+ documents to the U.S. Securities and Exchange Commission (SEC) since 2025. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Kestra Medical Technologies's financial statements. The most recent filing was a Form 4 submitted on November 19, 2026.

Form 4
KESTRA MEDICAL TECHNOLOGIES, LTD. Reports Ownership Change on Nov. 19, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

10-Q
Kestra Medical Technologies Files Quarterly Report on Sep. 14, 2026

The 10-Q contains Kestra Medical Technologies's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Kestra Medical Technologies SEC Filing History

Browse Kestra Medical Technologies' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

Filing Date
0 Results
DateFilerForm TypeView
11/19/2026 3:06 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2026 3:12 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2026 4:41 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2026 3:12 PM
Kestra Medical Technologies (1877184) Subject
Moran Timothy P. (1753958) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2026 5:44 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2026 5:46 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2026 3:37 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2026 3:36 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/27/2026 3:09 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/27/2026 3:12 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2026 3:24 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2026 3:26 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2026 3:01 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/20/2026 3:03 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2026 5:00 PM
COHEN RAYMOND W (1258288) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2026 3:06 PM
COHEN RAYMOND W (1258288) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2026 5:04 PM
Kestra Medical Technologies (1877184) Issuer
Kwo Elizabeth (1820001) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2026 3:01 PM
Kestra Medical Technologies (1877184) Subject
Kwo Elizabeth (1820001) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/14/2026 4:15 PM
Kestra Medical Technologies (1877184) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/14/2026 3:04 PM
Kestra Medical Technologies (1877184) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2026 7:43 PM
Kestra Medical Technologies (1877184) Issuer
Schwartz Jeffrey Lawrence (1702957) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 7:25 PM
Kestra Medical Technologies (1877184) Issuer
Ladone Mary Kay (1760737) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 7:26 PM
Kestra Medical Technologies (1877184) Issuer
Reilly Kevin C (1958127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 7:28 PM
Hanley Conor (2072296) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 7:30 PM
COHEN RAYMOND W (1258288) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 7:31 PM
Kestra Medical Technologies (1877184) Issuer
Kwo Elizabeth (1820001) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2026 4:16 PM
Kestra Medical Technologies (1877184) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2026 6:16 PM
Kestra Medical Technologies (1877184) Subject
Schwartz Jeffrey Lawrence (1702957) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2026 3:13 PM
Kestra Medical Technologies (1877184) Subject
Ladone Mary Kay (1760737) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2026 3:13 PM
Kestra Medical Technologies (1877184) Subject
Reilly Kevin C (1958127) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/08/2026 3:15 PM
Hanley Conor (2072296) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2026 6:01 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2026 3:51 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2026 9:38 AM
Kestra Medical Technologies (1877184) Subject
PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by
Form SCHEDULE 13G/A
08/11/2026 4:56 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 5:59 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 6:01 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 6:04 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2026 6:06 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 3:30 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2026 3:32 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
The next convergence is here (Ad)

In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel

See the three companies positioned for uranium's next supply shock
08/04/2026 3:33 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2026 3:35 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2026 6:26 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2026 6:29 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2026 6:30 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2026 6:32 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2026 6:35 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2026 3:40 PM
Kestra Medical Technologies (1877184) Subject
Moran Timothy P. (1753958) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2026 3:41 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2026 3:42 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2026 3:44 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2026 3:27 PM
Kestra Medical Technologies (1877184) Subject
Moran Timothy P. (1753958) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2026 3:29 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2026 3:31 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2026 3:33 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2026 3:39 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2026 3:39 PM
Kestra Medical Technologies (1877184) Subject
Moran Timothy P. (1753958) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2026 3:30 PM
Kestra Medical Technologies (1877184) Subject
Mahboob Vaseem (1655157) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2026 3:33 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2026 3:36 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2026 4:48 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2026 4:49 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2026 4:50 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2026 4:51 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2026 4:52 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2026 3:20 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2026 4:16 PM
Kestra Medical Technologies (1877184) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
07/14/2026 3:08 PM
Kestra Medical Technologies (1877184) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2026 4:15 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2026 4:16 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2026 3:36 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2026 4:10 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2026 5:37 PM
Kestra Medical Technologies (1877184) Issuer
Mahboob Vaseem (1655157) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:39 PM
Ford Alfred J Jr (1359446) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:40 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:35 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2026 5:36 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 4:40 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 3:15 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2026 4:03 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2026 3:18 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2026 2:25 PM
Kestra Medical Technologies (1877184) Subject
PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by
Form SCHEDULE 13G/A
04/01/2026 3:30 PM
Kestra Medical Technologies (1877184) Filer
Form S-3ASR
03/30/2026 5:06 PM
COHEN RAYMOND W (1258288) Reporting
Kestra Medical Technologies (1877184) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2026 3:10 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2026 5:17 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2026 4:14 PM
Kestra Medical Technologies (1877184) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/12/2026 3:16 PM
Kestra Medical Technologies (1877184) Issuer
Reilly Kevin C (1958127) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2026 3:35 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2026 3:30 PM
Bain Charger Holdings, L.P. (1876077) Filed by
Kestra Medical Technologies (1877184) Subject
Form SCHEDULE 13G/A
Top Trader Reveals Stunning Black Friday Deal (Ad)

Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel

Get the Snapback Indicator for just $7 in the Black Friday sale today.
02/17/2026 9:26 AM
Kestra Medical Technologies (1877184) Subject
PRICE T ROWE ASSOCIATES INC /MD/ (80255) Filed by
Form SCHEDULE 13G
01/20/2026 5:00 AM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 3:16 PM
Kestra Medical Technologies (1877184) Issuer
Umberger Traci S (1877198) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2025 3:14 PM
Kestra Medical Technologies (1877184) Issuer
Webster Brian Daniel (1877188) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2025 3:35 PM
Kestra Medical Technologies (1877184) Subject
Webster Brian Daniel (1877188) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2025 3:36 PM
Kestra Medical Technologies (1877184) Subject
Umberger Traci S (1877198) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2025 4:16 PM
Kestra Medical Technologies (1877184) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/04/2025 8:48 PM
Kestra Medical Technologies (1877184) Issuer
Moran Timothy P. (1753958) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2025 3:30 PM
Kestra Medical Technologies (1877184) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Kestra Medical Technologies SEC Filings - Frequently Asked Questions

Kestra Medical Technologies (KMTS) has submitted 146+ filings to the SEC since 2025. You can browse the complete history or filter by form type using the tools above.

Kestra Medical Technologies's fiscal year ends on April 30. The company typically files its 10-K annual report by the end of June, covering the prior fiscal year's financial results. Key financial data from these reports is available on Kestra Medical Technologies's financial statements page.

The most recent filing was a Form 4 submitted on November 19, 2026. This was an insider ownership change filed by 4 - KESTRA MEDICAL TECHNOLOGIES, LTD. (0001877184) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:KMTS are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 11/19/2026. New filings are added as they're published.
From Our Partners